Sacral Nerve Stimulation Devices Market Growth Trajectory Through 2024-2033

The Sacral Nerve Stimulation Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Sacral Nerve Stimulation Devices Market:
https://www.thebusinessresearchcompany.com/report/sacral-nerve-stimulation-devices-global-market-report

According to The Business Research Company’s Sacral Nerve Stimulation Devices Global Market Report 2024, The sacral nerve stimulation devices market size has grown rapidly in recent years. It will grow from $1.19 billion in 2023 to $1.33 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to the increasing prevalence of urinary and fecal incontinence, advancements in neuromodulation technology, rising awareness of non-surgical treatment options, favorable reimbursement policies, growing geriatric population, higher incidences of neurological disorders, and increased healthcare spending.

The sacral nerve stimulation devices market size is expected to see rapid growth in the next few years. It will grow to $2.08 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to improvements in reimbursement policies, greater acceptance of neuromodulation therapies, increasing preference for non-invasive or minimally invasive treatments, the exploration of sacral nerve stimulation devices, increasing preference among patients and healthcare providers, favorable regulatory environments, rising healthcare expenditure globally. Major trends in the forecast period include advances in miniaturization and implantable technologies, exploration of sacral nerve stimulation devices, development of external sacral nerve stimulation devices, patient education, and awareness, regulatory advances, market access, spinal cord stimulation, or peripheral nerve stimulation.

The increasing prevalence of urological disorders is expected to propel the growth of the sacral nerve stimulation devices market going forward. Urologic disorders encompass a range of conditions affecting the urinary tract, kidneys, bladder, and prostate, varying in duration from acute to chronic. Urological disorders can arise from various causes, affecting the urinary tract and the reproductive organs. Additionally, lifestyle factors such as poor diet, dehydration, and lack of exercise, can contribute to the development of kidney stones, a painful condition affecting the urinary tract. Sacral nerve stimulation devices provide a minimally invasive treatment option that can effectively manage urological disorders such as urinary and fecal incontinence. For instance, in April 2024, according to the National Institute of Diabetes and Digestive and Kidney Diseases, a US-based healthcare company, on average each year, 651,446 individuals aged 65 and older (212,875 men and 438,572 women) were newly diagnosed with any form of urinary incontinence. Therefore, the increasing prevalence of urological disorders will drive the growth of the sacral nerve stimulation devices market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=18458&type=smp

The sacral nerve stimulation devices market covered in this report is segmented –

1) By Type: Electrical Muscle Stimulation, Transcutaneous Electrical Nerve Stimulation
2) By Product: External Sacral Nerve Stimulation (SNS) Devices, Implantable Sacral Nerve Stimulation (SNS) Devices
3) By Age: Pediatrics, Adults, Geriatrics
4) By Application: Urinary Incontinence, Fecal Incontinence, Other Applications
5) By End User: Hospital, Ambulatory Surgical Centers, Specialty Clinics

Major companies operating in the sacral nerve stimulation devices market are developing innovative products, such as next-generation sacral neuromodulation devices, to improve patient outcomes, enhance device efficacy, and reduce adverse side effects. Next-generation sacral neuromodulation devices are cutting-edge tools that offer enhanced control and efficiency in stimulating sacral nerves. For instance, in February 2022, Medtronic plc, an Ireland-based medical device company, launched the InterStim X. It is a next-generation device designed for sacral neuromodulation therapy used to treat conditions such as overactive bladder (OAB) and chronic fecal incontinence and non-obstructive urinary retention. InterStim X offers long-term, personalized treatment without the need for recharging. The device is recharge-free, offering patients a decade or more of therapy without recharging, enhancing convenience and compliance.

The sacral nerve stimulation devices market report table of contents includes:

1. Executive Summary
2. Sacral Nerve Stimulation Devices Market Characteristics
3. Sacral Nerve Stimulation Devices Market Trends And Strategies
4. Sacral Nerve Stimulation Devices Market – Macro Economic Scenario
5. Global Sacral Nerve Stimulation Devices Market Size and Growth
.
.
.
32. Global Sacral Nerve Stimulation Devices Market Competitive Benchmarking
33. Global Sacral Nerve Stimulation Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Sacral Nerve Stimulation Devices Market
35. Sacral Nerve Stimulation Devices Market Future Outlook and Potential Analysis
36. Appendix